Abstract
The EU drugs strategy (2013-2020) and the EU action plan (2013-2016) were endorsed by the Justice and Home Affairs Council of the European Union respectively on 7 December 2012 and on 6 June 2013. The main features of the current strategy and its first action plan, and how they aim to address Europes changing drugs problem, are presented in this analysis.<br/>Part of the Perspectives on drugs (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
